Austin Chiang, MD, MPH: One innovation that's happening in my specialty of gastroenterology is artificial intelligence. Ben ...
From the column: "You’ve heard about dedicated runners “hitting the wall?” Finishing your prep is kind of like that." ...
CARDIFF, UK / ACCESS Newswire / February 12, 2025 / Biodexa Pharmaceuticals PLC. (NASDAQ:BDRX), a clinical-stage biopharmaceutical company developing a pipeline of innovative products for the treatmen ...
CARDIFF, UK / ACCESS Newswire / February 12, 2025 / Biodexa Pharmaceuticals PLC. , a clinical-stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases ...
1d
Hosted on MSN8 Risk Factors of Colon Cancer and How to Check for SignsIt makes knowing the signs of a developing medical condition and taking steps to prevent it all the more valid. Below, we ...
Sanford developed a database of who should be sent a home screening kit. The number they came up with is a big one.
The Fast Track designation is supported by data from a phase 2 trial that evaluated eRapa in 30 adult patients with FAP.
Biodexa Receives US FDA Fast Track Designation for eRapa in Familial Adenomatous Polyposis Underscores unmet need for a ...
CHENNAI: Ever wondered how digestion happens in the body? The food we eat transverse through four tubes — the oesophagus, ...
Aneurin Bevan University Health Board (ABUHB) has become the first in Wales to pilot a groundbreaking technology transforming ...
A health board has become the first in Wales to implement a technology to treat Colon cancer, developed by Welsh med-tech company Creo Medical.
Investment analysts at StockNews.com started coverage on shares of Check-Cap (NASDAQ:CHEK – Get Free Report) in a research note issued on Wednesday. The firm set a “sell” rating on the medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results